These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19747969)

  • 21. Effective antitumor activity of paclitaxel-loaded poly (epsilon-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model.
    Ma G; Yang J; Zhang L; Song C
    Anticancer Drugs; 2010 Mar; 21(3):261-9. PubMed ID: 20016371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel.
    Jackson JK; Gleave ME; Yago V; Beraldi E; Hunter WL; Burt HM
    Cancer Res; 2000 Aug; 60(15):4146-51. PubMed ID: 10945622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate.
    Mo Y; Lim LY
    J Control Release; 2005 Sep; 107(1):30-42. PubMed ID: 16051391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films.
    Liu R; Wolinsky JB; Walpole J; Southard E; Chirieac LR; Grinstaff MW; Colson YL
    Ann Surg Oncol; 2010 Apr; 17(4):1203-13. PubMed ID: 19957041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant.
    Shikanov A; Shikanov S; Vaisman B; Golenser J; Domb AJ
    Int J Pharm; 2008 Jun; 358(1-2):114-20. PubMed ID: 18406086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting.
    Lu H; Li B; Kang Y; Jiang W; Huang Q; Chen Q; Li L; Xu C
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):175-81. PubMed ID: 16718469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel-incorporated nanoparticles of hydrophobized polysaccharide and their antitumor activity.
    Lee SJ; Hong GY; Jeong YI; Kang MS; Oh JS; Song CE; Lee HC
    Int J Pharm; 2012 Aug; 433(1-2):121-8. PubMed ID: 22561793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation.
    Lapidus RG; Dang W; Rosen DM; Gady AM; Zabelinka Y; O'Meally R; DeWeese TL; Denmeade SR
    Prostate; 2004 Feb; 58(3):291-8. PubMed ID: 14743469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.
    Xie M; Zhou L; Hu T; Yao M
    Anticancer Drugs; 2007 Apr; 18(4):459-66. PubMed ID: 17351398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
    Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
    Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
    Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
    J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
    Park JS; Han TH; Lee KY; Han SS; Hwang JJ; Moon DH; Kim SY; Cho YW
    J Control Release; 2006 Sep; 115(1):37-45. PubMed ID: 16935380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel paclitaxel nanoparticles: development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation.
    Shavi GV; Kumar AR; Karthik A; Naseer M; Aravind G; Praful BD; Reddy MS; Udupa N
    J Control Release; 2010 Nov; 148(1):e119-21. PubMed ID: 21529590
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
    Ranganath SH; Fu Y; Arifin DY; Kee I; Zheng L; Lee HS; Chow PK; Wang CH
    Biomaterials; 2010 Jul; 31(19):5199-207. PubMed ID: 20350766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
    Devalapally H; Shenoy D; Little S; Langer R; Amiji M
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery.
    Alipour S; Montaseri H; Tafaghodi M
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):521-9. PubMed ID: 20732796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel-loaded expansile nanoparticles in a multimodal treatment model of malignant mesothelioma.
    Schulz MD; Zubris KA; Wade JE; Padera RF; Xu X; Grinstaff MW; Colson YL
    Ann Thorac Surg; 2011 Dec; 92(6):2007-13; discussion 2013-4. PubMed ID: 21963198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.